S&P 500   3,941.26
DOW   33,596.34
QQQ   281.68
Franchising Could Be the Secret to Reaping the Rewards of a Down Economy. Here Are 5 Reasons Why.
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
3 Big Box Retail Bets for the Holidays
How Long Does it Take to Become a Profitable Trader?
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Biden visits Arizona computer chip site, highlights jobs
Is Autozone Ready To Rally For Another Profitable Lap?
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Trump Org. jury seeks clarity as deliberations continue
Biden to visit Arizona computer chip site, highlight jobs
S&P 500   3,941.26
DOW   33,596.34
QQQ   281.68
Franchising Could Be the Secret to Reaping the Rewards of a Down Economy. Here Are 5 Reasons Why.
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
3 Big Box Retail Bets for the Holidays
How Long Does it Take to Become a Profitable Trader?
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Biden visits Arizona computer chip site, highlights jobs
Is Autozone Ready To Rally For Another Profitable Lap?
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Trump Org. jury seeks clarity as deliberations continue
Biden to visit Arizona computer chip site, highlight jobs
S&P 500   3,941.26
DOW   33,596.34
QQQ   281.68
Franchising Could Be the Secret to Reaping the Rewards of a Down Economy. Here Are 5 Reasons Why.
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
3 Big Box Retail Bets for the Holidays
How Long Does it Take to Become a Profitable Trader?
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Biden visits Arizona computer chip site, highlights jobs
Is Autozone Ready To Rally For Another Profitable Lap?
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Trump Org. jury seeks clarity as deliberations continue
Biden to visit Arizona computer chip site, highlight jobs
S&P 500   3,941.26
DOW   33,596.34
QQQ   281.68
Franchising Could Be the Secret to Reaping the Rewards of a Down Economy. Here Are 5 Reasons Why.
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
3 Big Box Retail Bets for the Holidays
How Long Does it Take to Become a Profitable Trader?
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Biden visits Arizona computer chip site, highlights jobs
Is Autozone Ready To Rally For Another Profitable Lap?
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War (Ad)
Trump Org. jury seeks clarity as deliberations continue
Biden to visit Arizona computer chip site, highlight jobs
NASDAQ:EPIX

ESSA Pharma - EPIX Stock Forecast, Price & News

$3.32
-0.15 (-4.32%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.23
$3.44
50-Day Range
$1.50
$4.82
52-Week Range
$1.40
$14.88
Volume
91,586 shs
Average Volume
1.12 million shs
Market Capitalization
$146.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00

ESSA Pharma MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
502.4% Upside
$20.00 Price Target
Short Interest
Healthy
3.34% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$5.97 M Bought Last Quarter
Proj. Earnings Growth
Decreasing
From ($0.94) to ($1.16) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.77 out of 5 stars

Medical Sector

801st out of 1,023 stocks

Pharmaceutical Preparations Industry

395th out of 501 stocks

EPIX stock logo

About ESSA Pharma (NASDAQ:EPIX) Stock

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Receive EPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter.

EPIX Stock News Headlines

ESSA Pharma Inc
ESSA Pharma Inc.: Selling For Under Cash Value
Multiple Ongoing Studies of EPI-7386
EPIX Stock Gains 11.6% on Insider Buys
ESSA Pharma Inc.(EPIX)
See More Headlines
Receive EPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter.

EPIX Company Calendar

Last Earnings
11/18/2021
Today
12/06/2022
Next Earnings (Estimated)
2/01/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EPIX
Employees
25
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$20.00
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+502.4%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-36,810,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.41 per share

Miscellaneous

Free Float
39,710,000
Market Cap
$146.32 million
Optionable
Not Optionable
Beta
2.04

Key Executives

  • Dr. David Ross Parkinson M.D. (Age 72)
    Pres, CEO & Director
    Comp: $829.56k
  • Mr. David S. Wood C.M.A. (Age 65)
    CPA, M.B.A., MBA, CPA, CMA, Chief Financial Officer
    Comp: $532.35k
  • Mr. Peter A. Virsik M.B.A. (Age 51)
    M.S., Exec. VP & COO
    Comp: $646.75k
  • Dr. Alessandra Cesano M.D. (Age 62)
    Ph.D., Chief Medical Officer
    Comp: $620.81k
  • Chandtip Chandhasin
    Exec.
  • Erica Osbourne
    Exec.
  • Erin Rudsinski
    Exec.
  • Loleta Harris
    Exec.
  • Neil Thapar
    Exec.
  • Nkengyal Barber
    Exec.













EPIX Stock - Frequently Asked Questions

What is ESSA Pharma's stock price forecast for 2023?

0 Wall Street analysts have issued 12-month price objectives for ESSA Pharma's shares. Their EPIX share price forecasts range from $20.00 to $20.00. On average, they expect the company's stock price to reach $20.00 in the next year. This suggests a possible upside of 502.4% from the stock's current price.
View analysts price targets for EPIX
or view top-rated stocks among Wall Street analysts.

How have EPIX shares performed in 2022?

ESSA Pharma's stock was trading at $14.20 at the beginning of the year. Since then, EPIX stock has decreased by 76.6% and is now trading at $3.32.
View the best growth stocks for 2022 here
.

Are investors shorting ESSA Pharma?

ESSA Pharma saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 618,300 shares, a decline of 69.4% from the October 31st total of 2,020,000 shares. Based on an average daily volume of 3,200,000 shares, the short-interest ratio is presently 0.2 days. Approximately 3.3% of the shares of the company are sold short.
View ESSA Pharma's Short Interest
.

When is ESSA Pharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our EPIX earnings forecast
.

How were ESSA Pharma's earnings last quarter?

ESSA Pharma Inc. (NASDAQ:EPIX) posted its quarterly earnings data on Thursday, November, 18th. The company reported ($0.20) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.03.

What other stocks do shareholders of ESSA Pharma own?
What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the NASDAQ under the ticker symbol "EPIX."

Who are ESSA Pharma's major shareholders?

ESSA Pharma's stock is owned by a variety of retail and institutional investors. Top institutional investors include BVF Inc. IL (19.85%), Bellevue Group AG (13.38%), Eventide Asset Management LLC (3.54%), PFM Health Sciences LP (3.35%), RTW Investments LP (2.98%) and Bioimpact Capital LLC (0.92%). Insiders that own company stock include David Ross Parkinson, Franklin M Berger and Growth N V Biotech.
View institutional ownership trends
.

How do I buy shares of ESSA Pharma?

Shares of EPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ESSA Pharma's stock price today?

One share of EPIX stock can currently be purchased for approximately $3.32.

How much money does ESSA Pharma make?

ESSA Pharma (NASDAQ:EPIX) has a market capitalization of $146.32 million. The company earns $-36,810,000.00 in net income (profit) each year or ($0.86) on an earnings per share basis.

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 WEST BROADWAY SUITE 720, VANCOUVER A1, V5Z 1K5. The official website for the company is www.essapharma.com. The company can be reached via phone at 778-331-0962, via email at alada@troutgroup.com, or via fax at 604-738-4080.

This page (NASDAQ:EPIX) was last updated on 12/7/2022 by MarketBeat.com Staff